These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A CD40-CD154 interaction in tissue fibrosis. Kawai M, Masuda A, Kuwana M. Arthritis Rheum; 2008 Nov; 58(11):3562-73. PubMed ID: 18975310 [Abstract] [Full Text] [Related]
3. CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction. Wagner AH, Güldenzoph B, Lienenlüke B, Hecker M. Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):715-20. PubMed ID: 14976003 [Abstract] [Full Text] [Related]
4. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression. Galindo M, Santiago B, Rivero M, Rullas J, Alcami J, Pablos JL. Arthritis Rheum; 2001 Jun; 44(6):1382-6. PubMed ID: 11407698 [Abstract] [Full Text] [Related]
5. Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients. Valentini G, Romano MF, Naclerio C, Bisogni R, Lamberti A, Turco MC, Venuta S. J Autoimmun; 2000 Aug; 15(1):61-6. PubMed ID: 10936029 [Abstract] [Full Text] [Related]
6. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Chizzolini C, Raschi E, Rezzonico R, Testoni C, Mallone R, Gabrielli A, Facchini A, Del Papa N, Borghi MO, Dayer JM, Meroni PL. Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192 [Abstract] [Full Text] [Related]
7. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N. Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619 [Abstract] [Full Text] [Related]
8. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Distler JH, Jüngel A, Caretto D, Schulze-Horsel U, Kowal-Bielecka O, Gay RE, Michel BA, Müller-Ladner U, Kalden JR, Gay S, Distler O. Arthritis Rheum; 2006 Jan; 54(1):214-25. PubMed ID: 16385517 [Abstract] [Full Text] [Related]
10. In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro. Pasch MC, Timár KK, van Meurs M, Heydendael VM, Bos JD, Laman JD, Asghar SS. J Pathol; 2004 Jul; 203(3):839-48. PubMed ID: 15221944 [Abstract] [Full Text] [Related]
11. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis. Kawaguchi Y, Harigai M, Hara M, Fukasawa C, Takagi K, Tanaka M, Tanaka E, Nishimagi E, Kamatani N. J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882 [Abstract] [Full Text] [Related]
12. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts. Kawaguchi Y, McCarthy SA, Watkins SC, Wright TM. J Rheumatol; 2004 Oct; 31(10):1946-54. PubMed ID: 15468358 [Abstract] [Full Text] [Related]
13. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets. Thienel U, Loike J, Yellin MJ. Cell Immunol; 1999 Dec 15; 198(2):87-95. PubMed ID: 10648122 [Abstract] [Full Text] [Related]
14. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM. Arthritis Rheum; 1998 Nov 15; 41(11):2039-47. PubMed ID: 9811060 [Abstract] [Full Text] [Related]
15. Disruption of CD40/CD40 ligand interaction with cleavage of CD40 on human gingival fibroblasts by human leukocyte elastase resulting in down-regulation of chemokine production. Nemoto E, Tada H, Shimauchi H. J Leukoc Biol; 2002 Sep 15; 72(3):538-45. PubMed ID: 12223522 [Abstract] [Full Text] [Related]
16. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor. Takemura H, Suzuki H, Fujisawa H, Yuhara T, Akama T, Yamane K, Kashiwagi H. J Rheumatol; 1998 Aug 15; 25(8):1534-9. PubMed ID: 9712097 [Abstract] [Full Text] [Related]
17. Prospects for CD40-directed experimental therapy of human cancer. Tong AW, Stone MJ. Cancer Gene Ther; 2003 Jan 15; 10(1):1-13. PubMed ID: 12489023 [Abstract] [Full Text] [Related]
18. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. Sempowski GD, Chess PR, Phipps RP. J Immunol; 1997 May 15; 158(10):4670-7. PubMed ID: 9144479 [Abstract] [Full Text] [Related]
19. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Fuschiotti P, Medsger TA, Morel PA. Arthritis Rheum; 2009 Apr 15; 60(4):1119-28. PubMed ID: 19333920 [Abstract] [Full Text] [Related]
20. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse. Ong VH, Evans LA, Shiwen X, Fisher IB, Rajkumar V, Abraham DJ, Black CM, Denton CP. Arthritis Rheum; 2003 Jul 15; 48(7):1979-91. PubMed ID: 12847692 [Abstract] [Full Text] [Related] Page: [Next] [New Search]